Learn

Educational materials that cover the basics of hepatitis C, prevention, testing, treatment, and care to use in trainings and advocacy discussions.

Moldova’s Progressive Prison Reforms Cut HIV Transmission to Zero

Unlike many European countries that have abandoned needle and syringe exchange programs for inmates, Moldova has continued to press ahead with innovative prison reforms aimed at reducing the spread of diseases like HIV and hepatitis B and C. More

5 November 2024Learn Prevention

European Harm Reduction Services Adapt and Advance Amid COVID-19 Challenges

A study details the significant transformations in harm reduction services across Europe during the COVID-19 pandemic. More

17 October 2024Learn Prevention

Feasibility of Hepatitis C Elimination by Screening and Treatment Alone in High-Income Countries

A study develops an agent-based model to characterize the HCV epidemic in Canada, a resource-rich country with ongoing immigration from HCV-endemic regions, relying exclusively on risk-based screening for case identification. More

16 October 2024Learn Care

Prevention

Educational materials that cover preventative measures and harm reduction strategies to prevent the transmission of hepatitis C.

Rate of Hepatitis C Reinfection After Successful Treatment Among PWID in Spain

Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study More

25 November 2024Learn Prevention

Prevalence of HCV Infection Among People Experiencing Homelessness in Madrid, Spain

A study assessed risk factors, prevalence, and trends of active HCV infection among people experiencing homelessness in Madrid, Spain (2019-2023). More

7 November 2024Learn Prevention

Prevention: all materials

Diagnostics

Educational materials that cover basics of hepatitis C testing and barriers to getting diagnosed.

New Research Supports Universal HCV Screening Over Risk-Based Testing

The study found 1.4 million people aged 12-59 with current HCV infection, including over 500,000 without injection drug use history. More

6 November 2024Learn Diagnostics

Point-of-Care HCV RNA Test Could Expedite Diagnosis, Treatment in High-Risk Settings

Findings support the feasibility and clinical performance of Xpert HCV, the first FDA-approved point-of-care test for diagnosing HCV, in a nonclinical justice setting. More

16 October 2024Learn Diagnostics

Diagnostics: all materials

Treatment

Treatment literacy materials that cover the basics of hepatitis C treatment, research on efficacy in different key populations, and global treatment uptake.

Efficacy of 8-Week Daclatasvir-Sofosbuvir Regimen for Chronic Hepatitis C

Results suggest a shorter treatment duration could reduce costs and improve access in low- and middle-income countries. More

25 November 2024Learn Treatment

Artificial Intelligence-Assisted Identification and Retrieval of HCV Patients Lost to Follow-up in Spain

A study identified and relinked to care HCV patients previously lost to medical follow-up in Spain using an artificial intelligence-assisted system. More

13 August 2024Learn Treatment

Treatment: all materials

Care: all materials